Clinical Trials for Frontera Therapeutics

Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa

Gene Therapy for DME

Gene Therapy(FT-003) for Wet AMD

Gene Therapy for Diabetic Macular Edema

Gene Therapy for Wet AMD

Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa

Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy